Figures & data
Figure 1 Summary plot for adverse outcomes 80mg.
Figure 2 Summary plot for adverse outcomes 120mg.
Figure 3 Summary plot for glycemic parameters 80mg.
Figure 4 Summary plot for glycemic parameters 120mg.
Diabetes, Metabolic Syndrome and Obesity
Volume 16, 2023 - Issue
REVIEW
Evaluating Glycemic Control Efficacy and Safety of the Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis
, 
, , , , , & show all
Hussain Sohail Rangwala1 Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistanhttps://orcid.org/0009-0007-2167-3481
https://orcid.org/0009-0007-2167-3481, Muhammad Saqlain Mustafa1 Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistanhttps://orcid.org/0000-0002-3067-3543
https://orcid.org/0000-0002-3067-3543, Muhammad Ashir Shafique1 Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistanhttps://orcid.org/0000-0001-7420-1292
https://orcid.org/0000-0001-7420-1292, , , Tagwa Kalool Fadlalla Ahmed4 Department of Medicine, Ahfad University for Women, Omdurman, Al-Khartum, SudanCorrespondence[email protected]
https://orcid.org/0009-0005-3942-9554
https://orcid.org/0009-0005-3942-9554 & Ainan Arshad3 Department of Medicine, Aga Khan University Hospital, Karachi, Pakistanhttps://orcid.org/0000-0002-9013-3899
https://orcid.org/0000-0002-9013-3899 show all